Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients

Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients

Genomic tests are the fastest growing sector in medicine and medical science, yet there remains a dearth of research on access to pharmacogenomic tests and medications. The objective of this study is to explore providers’ and patients’ experiences and views on test access as well as strategies used...

Full description

Bibliographic Details
Main Authors: Ann Chen Wu, Kathleen M. Mazor, Rachel Ceccarelli, Stephanie Loomer, Christine Y. Lu
Format: Article
Language:English
Published: MDPI AG 2017-11-01
Series:Journal of Personalized Medicine
Subjects:
pharmacogenomic tests
cancer
access
providers
patients
Online Access:https://www.mdpi.com/2075-4426/7/4/17

Similar Items

Similar Items